Business
Cortacare receives positive opinion from CVMP
Cortacare receives positive opinion from CVMP.
About this update from Animalcare Group Plc
[{"type":"text","content":"\n \nRNS Number : 9706T Animalcare Group PLC 09 July 2018 \n\n \n09 July 2018\n \nAnimalcare Group plc\n \n(\"Animalcare\", the \"Company\" or the \"Group\")\n \nCortacare recommended for European marketing approval by CVMP \n \n- Launch in European markets expected in Q4 2018\n- Expands Animalcare's dermatology portfolio\n \nAnimalcare Group plc (AIM:ANCR), the pan-European animal health business, today announces that it has received a positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP), recommending European marketing authorisation for its dermatology product Cortacare. Animalcare plans to launch Cortacare in Q4 2018 through its direct sales operations in seven European countries and international distribution network.\nCortacare is a wholly-owned product, developed by Animalcare as a cutaneous spray for the treatment of inflammatory and pruritic dermatitis in dogs. The product is a corticosteroid designed to be applied topically to reduce inflammation and itching, which complements Animalcare's existing dermatology portfolio. Cortacare accumulates in the dog's skin, allowing for high local activity whilst minimising side effects, and leading to an improvement of skin lesions associated with the condition.\nChris Cardon, CEO of Animalcare Group plc, commented:\n\"As part of the reprioritisation of our product development pipeline we identified 17 core development products. We are pleased to see the first of these receive a positive recommendation from the CVMP, which paves the way for the commercialisation of this wholly owned product across Europe and expands our existing dermatology portfolio. Product development remains a key area for us and we are focused on building value within our development pipeline. We look forward to announcing further success as the pipeline progresses.\" \nEnquiries:\n \n\n\n\nAnimalcare Group plc\n\n\n\n\n\n\n\n\n\n\nChris Cardon, Chief Executive Officer\n\n\n\n\n\nTel: 01904 487 687\n\n\n\n\nChris Brewster, Chief Financial Officer\n\n\n\n\n\n\n\n\n\n\nPanmure Gordon (UK) Ltd (Nominated Adviser & Broker)\n\n\nTel: 020 7886 2500\n\n\n\n\nCorporate Finance\n\n\n\n\n\n\n\n\n\n\nFreddy Crossley / Peter Steel\n\n\n\n\n\n\n\n\n\n\nCorporate Br...